IceCure Medical
ICCM
8 hedge funds and large institutions have $85.3K invested in IceCure Medical in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
11% less funds holding
Funds holding: 9 → 8 (-1)
51% less capital invested
Capital invested by funds: $174K → $85.3K (-$89.1K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$14.2K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$4.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$78K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.86K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$296 |
ICCM Hedge Fund Activity: Q3 2022 in Review
8 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q3 2022, worth a combined $85.3K — down 51% from $174K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ICCM and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was Bank of America, adding an estimated $14.2K. The largest seller was JP Morgan Chase, exiting entirely with an estimated $78K sold.
- 8 institutional investors held IceCure Medical (ICCM) as of Q3 2022, down from 9 in Q2 2022.
- Funds reported $85.3K of IceCure Medical stock for Q3 2022, down 51% quarter-over-quarter.
- 0 funds opened new IceCure Medical positions in Q3 2022 and 1 closed out, a net change of -1 holder.
- The largest IceCure Medical buyer in Q3 2022 was Bank of America, an estimated $14.2K added.
- The largest IceCure Medical seller in Q3 2022 was JP Morgan Chase, an estimated $78K sold.
Based on aggregated 13F filings for Q3 2022.